AlphaFold 3 Wins Major Award by End of 2024? | Categorical | | | 6 months ago | |
AlphaFold 3 Open-Sourced by End of 2024? | Binary | | | 6 months ago | |
First Drug Designed with AlphaFold 3 in Clinical Trials by June 2025? | Binary | | | 6 months ago | |
First Major Pharma to Announce Collaboration with AlphaFold 3? | Categorical | | | 6 months ago | |
AlphaFold 3 Predicts New Protein Structure Leading to Breakthrough Study by March 2025? | Binary | | | 6 months ago | |
What will be GSK's liability costs from Zantac lawsuits by end of 2024? | Categorical | | | 7 months ago | |
Will GSK, Pfizer, and Sanofi settle Zantac lawsuits by end of 2024? | Binary | | | 7 months ago | |
How will GSK's market share in the pharmaceutical industry change by end of 2024? | Categorical | | | 7 months ago | |
Will GSK's stock recover to pre-ruling levels by Oct 31, 2024? | Binary | | | 7 months ago | |
Sanofi Stock Price Change Within One Week After FDA Decision on Dupixent | Categorical | | | 7 months ago | |
Market Share of Dupixent in COPD Treatments in Europe by end of 2024 | Categorical | | | 7 months ago | |
Will Dupixent sales grow in Q4 2024? | Binary | | | 7 months ago | |
Will Dupixent receive additional approvals for new indications by end of 2024? | Binary | | | 7 months ago | |
FDA Approval of Dupixent for COPD by September 27, 2024? | Binary | | | 7 months ago | |
Dupixent's Ranking Among Top-Selling Drugs Worldwide in 2024 | Categorical | | | 7 months ago | |
What regulatory changes will occur in pharmaceutical practices by the end of 2025? | Categorical | | | 7 months ago | |
Will Bristol-Myers and Sanofi's stock price drop by more than 5% by June 21, 2024? | Binary | | | 7 months ago | |
How will major healthcare providers and insurers respond to the Bristol-Myers and Sanofi ruling by end of 2024? | Categorical | | | 7 months ago | |
Will other states file similar lawsuits against Bristol-Myers and Sanofi by the end of 2024? | Binary | | | 7 months ago | |
Will Bristol-Myers and Sanofi appeal the Hawaii Plavix case ruling by end of 2024? | Binary | | | 7 months ago | |
How will Bristol-Myers and Sanofi's global sales be affected in 2024? | Categorical | | | 7 months ago | |
Market response to Sanofi's AI-driven R&D by end of 2024 | Categorical | | | 7 months ago | |
Sanofi to release an AI-developed drug by end of 2025? | Binary | | | 7 months ago | |
Formation Bio to secure more major partnerships by end of 2024? | Binary | | | 7 months ago | |
Sanofi stock price reaction post-expansion completion | Categorical | | | 7 months ago | |
Sanofi completes biomanufacturing expansion by end of 2025? | Binary | | | 7 months ago | |
Increase in Sanofi's vaccine production capacity by mid-2025? | Binary | | | 7 months ago | |
How will Novavax's stock perform by end of 2024? | Categorical | | | 8 months ago | |
Will the combined COVID-19 and flu vaccine be approved by end of 2024? | Binary | | | 8 months ago | |
Will Novavax's stock price double by end of 2024? | Binary | | | 8 months ago | |
Approval status of Novavax/Sanofi combination vaccine in major markets by the end of 2024 | Categorical | | | 8 months ago | |
Will Novavax's stock price exceed $300 by the end of 2024? | Binary | | | 8 months ago | |
Will Novavax and Sanofi complete their combination vaccine by the end of 2024? | Binary | | | 8 months ago | |
Which company will lead in COVID-19 vaccine market share by the end of 2024? | Categorical | | | 8 months ago | |
Global adoption level of Novavax-Sanofi vaccine by end of 2026 | Categorical | | | 8 months ago | |
Sanofi increases its stake in Novavax by end of 2024? | Binary | | | 8 months ago | |
Novavax-Sanofi COVID-Influenza vaccine launched by end of 2025? | Binary | | | 8 months ago | |
Novavax stock price doubles by end of 2024? | Binary | | | 8 months ago | |
Market Performance of Novavax-Sanofi Vaccine by 2024 | Categorical | | | 8 months ago | |
Global Reach of the Novavax-Sanofi Vaccine by 2024 | Categorical | | | 8 months ago | |
Novavax Stock Price Increase post-Deal Announcement? | Binary | | | 8 months ago | |
Combined COVID-19/Flu Vaccine Approval by 2024? | Binary | | | 8 months ago | |
U.S. to confirm over 30 human cases of H5 avian influenza by end of 2024? | Binary | | | 3 months ago | |
U.S. doubles bird flu vaccine stockpile by March 2025? | Binary | | | 3 months ago | |
Over 25 human H5 avian influenza cases in U.S. by end of 2024? | Binary | | | 3 months ago | |
Additional human H5 avian influenza cases in California by end of 2024? | Binary | | | 3 months ago | |
Will the U.S. double bird flu vaccine stock by March 31, 2025? | Binary | | | 3 months ago | |
Will new human H5 avian influenza cases be confirmed in the U.S. by end of 2024? | Binary | | | 3 months ago | |
Will Dupixent be approved for another indication by the FDA by end of 2024? | Binary | | | 3 months ago | |
Will FTC win the lawsuit against CVS, Cigna, and UnitedHealth over inflated insulin prices by September 30, 2025? | Binary | | | 3 months ago | |
Will CVS, Cigna, and UnitedHealth reach a settlement with the FTC over inflated insulin prices by December 31, 2024? | Binary | | | 3 months ago | |
What will be the outcome of the first major Zantac lawsuit trial by end of 2024? | Categorical | | | 7 months ago | |
Will GSK's appeal against the Delaware judge's ruling be successful by end of 2024? | Binary | | | 7 months ago | |
First AI-developed Sanofi drug type by end of 2025 | Categorical | | | 7 months ago | |
Sanofi's R&D efficiency increased significantly by mid-2025? | Binary | | | 7 months ago | |
Primary product type with boosted production at Sanofi by 2025 | Categorical | | | 7 months ago | |
Impact of Novavax-Sanofi partnership on Novavax's market position by end of 2024 | Categorical | | | 8 months ago | |
Will Sanofi increase its stake in Novavax beyond 5% by mid-2025? | Binary | | | 8 months ago | |
Will Novavax receive additional investment exceeding $200 million by mid-2025? | Binary | | | 8 months ago | |
Which company's stock performs better post-deal by the end of 2024, Novavax or Sanofi? | Categorical | | | 8 months ago | |
Development phase completion of Novavax-Sanofi COVID-Influenza vaccine by end of 2025 | Categorical | | | 8 months ago | |
Extent of Novavax stock price increase by end of 2024 | Categorical | | | 8 months ago | |
Second-Generation COVID-19 Vaccine Development Success by 2025 | Categorical | | | 8 months ago | |
Sanofi Increases Equity Stake in Novavax by 2024? | Binary | | | 8 months ago | |
Will Sanofi's stock price increase by 5% or more by March 31, 2025? | Binary | | | 6 days ago | |
Will Teva's stock price increase by 10% or more by March 31, 2025? | Binary | | | 6 days ago | |
Will Teva and Sanofi initiate Phase 3 trial for Duvakitug by June 30, 2025? | Binary | | | 6 days ago | |
Will Sanofi's Beijing insulin plant begin construction by end of 2025? | Binary | | | 20 days ago | |
Will regulatory issues delay Sanofi's Beijing facility construction by the end of 2024? | Binary | | | 20 days ago | |
Will Sanofi's Beijing insulin facility be operational by mid-2026? | Binary | | | 21 days ago | |
Will Sanofi complete the Beijing insulin facility by the end of 2025? | Binary | | | 20 days ago | |
Will the sale of Sanofi's 50% stake in Opella to CD&R receive regulatory approval by March 2025? | Binary | | | 2 months ago | |
Will CD&R announce layoffs in Sanofi's consumer health unit within a year of acquisition? | Binary | | | 2 months ago | |
Will CD&R complete the acquisition of Sanofi's consumer health unit by end of 2024? | Binary | | | 2 months ago | |
Which company will first deliver increased bird flu vaccines by March 31, 2025? | Categorical | | | 3 months ago | |
Will Recordati's stock price increase by 10% or more by December 31, 2024? | Binary | | | 3 months ago | |
Will Recordati complete contingent payments of $250 million to Sanofi by the end of 2026? | Binary | | | 3 months ago | |
Will Recordati's Enjaymo sales reach €250 million by the end of 2025? | Binary | | | 3 months ago | |
What will be the revenue growth rate of Sanofi and Regeneron for fiscal year 2024? | Categorical | | | 3 months ago | |
Will Dupixent reach $1 billion in US sales for COPD treatment by end of 2024? | Binary | | | 3 months ago | |
Will the FTC reach a settlement with CVS, Cigna, and UnitedHealth over the insulin price hike lawsuit by the end of 2024? | Binary | | | 3 months ago | |
Will FTC expand lawsuit to include insulin drugmakers Eli Lilly, Novo Nordisk, and Sanofi by end of 2024? | Binary | | | 3 months ago | |
Which company will be the first to settle with FTC over insulin price hike lawsuit by end of 2024? | Categorical | | | 3 months ago | |
Will FTC reach a settlement with CVS, Cigna, and UnitedHealth over insulin price hike lawsuit by end of 2024? | Binary | | | 3 months ago | |
Will FTC win the lawsuit against CVS, Cigna, and UnitedHealth over insulin price hike by end of 2024? | Binary | | | 3 months ago | |
Will FTC file lawsuit against Eli Lilly, Novo Nordisk, or Sanofi over insulin price inflation by Dec 31, 2024? | Binary | | | 3 months ago | |
Will FTC win lawsuit against CVS, Cigna, and UnitedHealth over insulin price inflation by Dec 31, 2024? | Binary | | | 3 months ago | |
Will CVS, Cigna, or UnitedHealth settle with FTC over insulin price inflation by Dec 31, 2024? | Binary | | | 3 months ago | |
Which company will be the first to settle with FTC over insulin price inflation by Dec 31, 2024? | Categorical | | | 3 months ago | |
Will FTC file lawsuits against Eli Lilly, Novo Nordisk, or Sanofi over insulin prices by December 31, 2024? | Binary | | | 3 months ago | |
Will CVS, Cigna, or UnitedHealth announce a significant reduction in insulin prices by June 30, 2025? | Binary | | | 3 months ago | |
Will FTC reach a settlement with CVS, Cigna, and UnitedHealth over insulin price inflation by end of 2024? | Binary | | | 3 months ago | |
Will FTC file additional lawsuits against Eli Lilly, Novo Nordisk, and Sanofi by June 30, 2025? | Binary | | | 3 months ago | |
Will the FTC file a lawsuit against Eli Lilly, Novo Nordisk, and Sanofi by December 31, 2024? | Binary | | | 3 months ago | |
Will the price of insulin decrease by at least 10% by December 31, 2024, as a result of the FTC lawsuit? | Binary | | | 3 months ago | |
Will the FTC lawsuit against CVS, Cigna, and UnitedHealth result in a settlement by September 30, 2024? | Binary | | | 3 months ago | |
Will FTC win lawsuit against CVS, Cigna, and UnitedHealth PBMs regarding insulin price inflation by end of 2024? | Binary | | | 3 months ago | |
Will FTC reach a settlement with Cigna’s Express Scripts over insulin price inflation by end of 2024? | Binary | | | 3 months ago | |
Will CVS, Cigna, or UnitedHealth be fined as a result of FTC lawsuit over insulin pricing by end of 2024? | Categorical | | | 3 months ago | |
Will FTC reach a settlement with UnitedHealth’s OptumRx over insulin price inflation by end of 2024? | Binary | | | 3 months ago | |